Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics
Clinical trial NCT01972711 · COMPLETED
Trial details
- NCT number
- NCT01972711
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-07-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.